Skip to main content
OpenTrials
Recruiting

NCT Number: NCT02869542

Institut Paoli Calmettes Lymphoma Database

Database of Institut Paoli-Calmettes patients diagnosed with lymphoma

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Lymphoma Hemic and Lymphatic Diseases Immune System Diseases Immunoproliferative Disorders Lymphatic Diseases Lymphoproliferative Disorders Neoplasms Neoplasms by Histologic Type

Age range

18 year–95 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Institut Paoli-Calmettes

Marseille, Bouches-du Rhône, 13009, France

Location status: Recruiting

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Hodgkin or non-hodgkin lymphoma

Exclusion criteria

  • Non applicable

Treatment and study plan

Data Collection

Other

Primary outcomes

  1. Survival of patients

    Time frame: 10 years

    Overall survival of all patients who come in the center

Secondary outcomes

  1. Collection of patients characteristics

    Time frame: 10 years

    Collection of characteristics of patients treated at Institut Paoli Calmettes in order to set up prospective and retrospective studies

Interested in participating?

Recruiting

Interested in participating?

Request Info

Sponsors and collaborators

Lead sponsor

Institut Paoli-Calmettes

Other

Registry information

Official study title

Institut Paoli Calmettes Breast Cancer Database

Important dates

Study start
2000
Primary completion
2030
Study completion
2030
First posted
Aug 17, 2016
Registry last updated
Aug 17, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.